Sep 3, 2026 08:00AM
Mar 23, 2026 09:03AM
Mar 23, 2026 09:00AM
Mar 4, 2026 08:00AM
Mar 4, 2026 08:00AM
Feb 3, 2026 07:31AM
Feb 3, 2026 07:30AM MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study
Oct 24, 2025 07:30AM
Oct 24, 2025 07:30AM
Oct 16, 2025 07:30AM
Oct 16, 2025 07:30AM
Sep 30, 2025 07:31AM
Sep 30, 2025 07:30AM
Sep 22, 2025 08:02AM MIRA reports positive Phase 1 trial results for ketamine analog Ketamir-2
Sep 22, 2025 08:00AM
Sep 16, 2025 07:30AM
Sep 16, 2025 07:30AM
Sep 12, 2025 07:30AM
Sep 12, 2025 07:30AM
Aug 19, 2025 08:30AM
Aug 19, 2025 08:30AM MIRA Pharmaceuticals Announces Completion of Phase 1 Single Ascending Dose for Oral Ketamir-2 with No Safety Concerns, Advances to Multiple Ascending Dose Stage
Aug 12, 2025 08:32AM
Aug 12, 2025 08:30AM
Jul 30, 2025 07:30AM
Jul 30, 2025 07:30AM
Jul 29, 2025 07:31AM
Jul 29, 2025 07:30AM
Jul 11, 2025 08:00AM MIRA reports anxiety reversal in animal study of obesity drug
Jul 11, 2025 08:00AM
Jul 3, 2025 08:02AM
Jul 3, 2025 08:00AM
Jun 30, 2025 08:00AM
Jun 25, 2025 08:00AM
Jun 18, 2025 08:31AM
Jun 18, 2025 08:30AM MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology
Jun 17, 2025 04:06PM
May 28, 2025 08:30AM
May 8, 2025 08:04AM
May 8, 2025 08:00AM
May 6, 2025 08:02AM
May 6, 2025 08:00AM
Apr 23, 2025 08:04AM Mira Pharma (MIRA) Reports Positive In Vitro Drug Release Data for Topical Ketamir-2
Apr 23, 2025 08:00AM
Apr 16, 2025 08:03AM
Apr 16, 2025 08:00AM
Apr 1, 2025 08:00AM
Mar 24, 2025 07:33AM
Mar 24, 2025 07:30AM
Jun 8, 2016 08:01AM Miramar Labs, Inc. Completes Alternative Public Offering, Raises $9.0 Million

1,188,206 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All